Renal blood flow and serotonin metabolism in tacrolimus treated rats

International Journal of Urology

Volumn 3, Issue 3, 1996, Pages 187-190

  Mugiya, Soichi ^a   Fujita, Kimio ^a   Malyszko, Jolanta ^a   Takada, Yumiko ^a   Takada, Akikazu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FK 506; Nephrotoxicity; Renal blood flow; Serotonin metabolism; Tacrolimus

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; SEROTONIN; TACROLIMUS;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; KIDNEY BLOOD FLOW; KIDNEY CORTEX; MALE; METABOLISM; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029952304     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00514.x     Document Type: Article

References (31)

1. Ueda D, Suzuki K, Kawabe K. Influence of FK 506 on renal blood flow. Transplant Proc 1993;25:2722-2723.
2. Ueda D, Tajima A, Ohtawara Y, Ishikawa A, Nakano M, Ushiyama T, Ohta N, Kawabe K, Aso Y. Influence of FK 506 on renal blood flow. Transplant Proc 1991;23:3121-3122.
3. Moutabarrik A, Ishibashi M, Fukunaga M, Kameoka H, Takano Y, Kokado Y, Takahara S, Jiang H, Sonoda T, Okuyama A. FK 506 mechanism of nephrotoxicity: stimmulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro. Transplant Proc 1991;23:3133-3136.
4. Benigni A, Morigi M, Perico N, Zoja C, Amuchastegui CS, Piccinelli A, Donadelli R, Remuzzi G. The acute effect of FK 506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992;54:775-780.
5. Nakahara H, Fukunaga M, Kakihara M, Horio M, Fujiwara Y, Fukuhara Y, Ueda N, Orita Y, Kamada T. Comparative effects of Cyclosporine A and FK-506 on endothelin secretion by a cultured renal cell line, LLC-PK1. J Cardiovasc Pharmacol 1991;17(suppl 7):S172-S173.
6. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki M, Ochiai T. FK 506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK 506 in vitro. J Antibiot 1987;40:1256-1265.
7. McCauley J. The nephrotoxicity of FK 506 as compared with cyclosporin. Curr Opin Nephrol Hypertens 1993;2:662-669.
8. Racusen LC, Solez K. Cyclosporine nephrotoxicit. Int Rev Exp Phthol 1988;30:107-157.
9. Copeland KR, Yatscoff RW. Comparison of the effects cyclosporine and its metabolites on the release of prostacyclin and endothelin from mesangial cells. Transplantation 1992;53:640-645.
10. De Clerk F, van Nueten JM, Reneman RS. Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review. Agents Actions 1984;15: 612-626.
11. Houston DS, Vanhoutte PM. Serotonin and the vascular system. Role in health and disease, and implications for therapy. Drugs 1986;31:149-163.
12. Ueda D, Suzuki K, Malyszko J, Pietraszek MH, Takada Y, Takada A, Kawabe K. Serotonergic measures in Cyclosporine A treated rats. Thromb Res 1994;76: 171-179.
13. Koshu K, Kamiyama K, Oka N, Endo S, Takaku A, Saito T. Measurement of refional blood flow using hydrogen gas generated by electrolysis. Stroke 1982; 13:483-487.
14. Stosseck K, Luebbers DW, Cottin N. Determination of local flow (microflow) by electrochemically generated hydrogen. Construction and application of the measuring probe. Pfluegers Arch 1974;348:225-238.
15. Anderson GM, Young JG, Cohen DJ, Schlicht KR, Patel N. Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma. Clin Chim 1981;27:775-776.
16. Van Nueten JM, Janssens WJ, Vanhoutte PM. Serotonin and the Cardiovascular System. Raven Press, New York, 1985.
17. Ueda D, Suzuki K, Malyszko J, Pietraszek MH, Takada Y, Takada A, Kawabe K. Fibrinolysis and serotonin under Cyclosporine A treatment in renal transplant recipients. Thromb Res 1994;76:97-102.
18. Grace AA, Barradas MA, Mikhaikidis DP, Jeremy JY, Moorhead JF, Sweny P, Dandona P. Cyclosporine A enhances platelet aggregation. Kidney Im 1987;32: 889-895.
19. Cohen H, Neild GH, Patel R, Mackie IJ, Machin SJ. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporine-treated renal allograft recipients. Thromb Res 1988;49:91-101.
20. 2 in rats caused by Cyclosporine. Transplantation 1985;40:214-216.
21. Nield GH, Rocchi G, Imberti L, Fumagalli F, Brown Z, Remuzzi G, Williams DG. Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb Res 1983;32:373-379.
22. Remuzzi G, Bertani T. Renal vascular and thrombotic effects of Cyclosporine. Am J Kidney Dis 1989;13:261-272.
23. Malyszko J, Takada Y, Urano T, Takada A. FK 506 affects platelet aggregation in vitro. Thromb Res 1994; 75:99-104.
24. van Zwieten PA. Pathophysiological relevance of serotonin. J Cardiovasc Pharmacol 1987;10(suppl 3): S19-S24.
25. Sebekova K, Raucinova M, Dzurik R. Serotonin metabolism in patients with decreased renal function. Nephron 1989;53:229-232.
26. McMaster P, Buist L. FK 506 in transplantation. Transplant Proc 1993;25:2684-2685.
27. Wallemacq PE, Reding R. FK 506 (Tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 1993;39:2219-2228.
28. Kumano K, Wang G, Endo T, Kuwano S. FK 506-induced nephrotoxicity in rats. Transplant Proc 1991; 23:512-515.
29. Yamada K, Sugisaki Y, Akimoto M, Yamanaka N. Short-term FK 5-6-induced morphological changes in rat kidneys. Transplant Proc 1991;23:3130-3132.
30. Thomson AW, Whiting PH, Blair JT, Davidson RJL, Simpson J. Pathological changes developing in the rat during a 3 week course of high dosage cyclosporin A and their reversal following drug withdrawal. Transplantation 1981;32:271-277.
31. McNally PG, Baker F, Milstry F, Walls J, Feehally J. Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat. Clin Sci 1991;81:271-279.